Inventor
BRUNE MICHAEL E
US12 patents
⚠️ This page may combine multiple inventors who share the name “BRUNE MICHAEL E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BITNER R SCOTT
5 patentsUS8993632B2Mar 31, 2015
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8716345B2May 6, 2014
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8415354B2Apr 9, 2013
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT1 citations48
US8198331B2Jun 12, 2012
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
BITNER R SCOTT0 citations48
US8940902B2Jan 27, 2015
Treatment of central nervous system disorders
BITNER R SCOTT0 citations47
ABBOTT LAB
4 patentsUS7511175B2Mar 31, 2009
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBOTT LAB18 citations92
US7855308B2Dec 21, 2010
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
ABBOTT LAB9 citations83
US7737137B2Jun 15, 2010
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
ABBOTT LAB7 citations72
US6323231B1Nov 27, 2001
Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
ABBOTT LAB9 citations70
ABBVIE INC
3 patentsUS9290444B2Mar 22, 2016
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations50
US9133145B2Sep 15, 2015
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
ABBVIE INC0 citations49
US9464072B2Oct 11, 2016
Treatment of central nervous system disorders
ABBVIE INC0 citations48